Nicardia-XL Contraindications

NICARDIA-XL-30 must not be administered to patients with cardiovascular shock, with narrowing of the aorta (higher-grade aortic stenosis), with known hypersensitivity to NICARDIA-XL-30, with unstable angina pectoris and acute myocardial infarction (within the first 4 weeks).
NICARDIA-XL-30 should not be used to patients with extremely low blood pressure (severe hypotension with systolic blood pressure under 90mmHg) or existing (decompensated) heart muscle weakness.
NICARDIA-XL-30 should not be used for the treatment of acute attacks of angina.
NICARDIA-XL-30 should not be used for secondary prevention of myocardial infarction.
NICARDIA-XL-30 should not be administered concomitantly with rifampicin since effective plasma levels of nifedipine may not be achieved owing to enzyme induction.
NICARDIA-XL-30 should not be administrated to patients with hepatic impairment.
NICARDIA-XL-30 should not be administrated to patients with a history of gastro-intestinal obstruction, oesophageal obstruction or any degree of decreased lumen diameter of the gastro-intestinal tract.
NICARDIA-XL-30 must not be used in patients with a history of gastro-intestinal obstruction, oesophageal obstruction, any degree of decreased lumen diameters of the gastro-intestinal tract.
NICARDIA-XL-30 must not use in patient with a Kock pouch (ileostomy after Proctocolectomy).
NICARDIA-XL-30 is contra-indicated in patients with inflammatory bowel disease or Crohn's disease.